Aerobid is a brand name of flunisolide, approved by the FDA in the following formulation(s):
AEROBID (flunisolide - aerosol, metered; inhalation)
Manufacturer: ROCHE PALO
Approval date: August 17, 1984
Strength(s): 0.25MG/INH [RLD]
Has a generic version of Aerobid been approved?
No. There is currently no therapeutically equivalent version of Aerobid available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aerobid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Aerobid.
See also...
- Aerobid Aerosol Inhaler Consumer Information (Wolters Kluwer)
- AeroBid Consumer Information (Cerner Multum)
- AeroBid AHFS DI Monographs (ASHP)
- Flunisolide Aerosol Inhaler Consumer Information (Wolters Kluwer)
- Flunisolide HFA Inhaler Consumer Information (Wolters Kluwer)
- Flunisolide inhalation Consumer Information (Cerner Multum)
- Flunisolide AHFS DI Monographs (ASHP)
No comments:
Post a Comment